Amide Bond Replacements Incorporated into CCK-B Selective “Dipeptoids”

Journal of Medicinal Chemistry

Volumn 35, Issue 8, 1992, Pages 1472-1484

  Fincham, Christopher I ^a   Higginbottom, Michael ^a   Hill, David R ^a   Horwell, David C ^a   O'Toole, John C ^a   Ratcliffe, Giles S ^a   Rees, David C ^a   Roberts, Edward ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; AMIDE; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; GASTRIN; LEUCINE ENKEPHALIN; LIGAND; METENKEPHALIN; PEPTIDE DERIVATIVE; RENIN; SOMATOSTATIN;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; METABOLISM; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

AMIDES; CHOLECYSTOKININ; COMPARATIVE STUDY; INDOLES; MEGLUMINE; MODELS, MOLECULAR; RECEPTORS, CHOLECYSTOKININ; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0026642964     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00086a017     Document Type: Article

References (43)

1. Humphrey, M. J.; Ringrose, P. S. Peptides and Related Drugs: A Review of their Absorption, Metabolism and Excretion. Drug Metab. Rev. 1986,17, 283-310.
2. Spatola, A. F. Peptide Backbone Modifications: A Structure-Activity Analysis of Peptides containing Amide Bond Surrogates. In Chemistry and Biochemistry of Amino Acids, Peptides and Proteins; Weinstein, B., Ed.; Dekker: New York, 1983; Vol. 7, Chapter 5.
3. Davies, J. S. Analogue and Conformational Studies on Peptide Hormones and Other Biologically Active Peptides. In Amino Acids and Peptides; Jones, J. H., Ed.; The Royal Society of Chemistry: London, 1986; Vol. 17, pp 104-125.
4. Amino Acids and Peptides 1987; Vol. 18, pp 140-168.
5. Amino Acids and Peptides 1987; Vol. 19, pp 141-189.
6. Amino Acids and Peptides 1989; Vol. 20, pp 128-174.
7. Amino Acids and Peptides 1990; Vol. 21, pp 129-173.
8. Rich, D. H. Peptidase Inhibitors. In Comprehensive Medicinal Chemistry; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon: New York, 1990; Vol. 2., Chapter 8.2, pp 391-441.
9. Page, M. I. Enzyme Inhibition. Comprehensive Medicinal Chemistry; Vol. 2, Chapter 5.4, pp 61-87.
10. Roberts, N. A.; Martin, J. A.; Kinchington, D.; Broadhurst, A. V.; Craig, J. C.; Duncan, I. B.; Galpin, S. A.; Hands, B. K.; Kay, J.; Króhn, A.; Lambert, R. W.; Merrett, J. H.; Mills, J. S.; Parkes, K. E. B.; Redshaw, S.; Ritchie, A. J.; Taylor, D. L.; Thomas, G.; Machin, P. J.; Rational Design of Peptide-Based HIV Proteinase Inhibitors. Science 1990, 248, 358-361.
11. Wolf, J-P.; Rapoport, H. Conformationally Constrained Peptides. Chirospecific Synthesis of 4-Alkyl-Substituted 7-Lactam-Bridged Dipeptides from l-Aspartic Acid. J. Org. Chem. 1989, 54, 3164-3173.
12. Jones, R. C. F.; Ward, G. J.; Amide Bond Isosteres: Imidazolines in Pseudopeptide Chemistry. Tetrahedron Lett. 1988,29, 3853-3856.
13. Arrowsmith, R. J.; Davies, D. E.; Fogden, Y. C.; Harris, C. J.; Thompson, C. ; Amino-Alcohol Dipeptide Analogues: A Simple Synthesis of a Versatile Isostere for the Development of Proteinase Inhibitors. Tetrahedron Lett. 1987, 28, 5569-5572.
14. Rich, D. H.; Green, J.; Toth, M. V.; Marshall, G. R.; Kent, S. B. H. Hydroxyethylamine Analogues of the p17/p24 Substrate Cleavage Site are Tight-Binding Inhibitors of HIV Protease. J. Med. Chem. 1990, 33,1285-1288.
15. Yasui, A.; Douglas, A. J.; Walker, B.; Magee, D. F.; Murphy, R. F. Novel C-Terminal Gastrin Antagonists. Int. J. Pept. Protein Res. 1990, 35, 301-305.
16. Rodriguez, M.; Aumelas, A.; Martinez, J. A General route to “Carba” Peptide Bond Replacements: Unequivocal Synthesis of Boc-L-Phe-4′(CH2-CH2)-L-Ala-OH and Boc-L,-Phe-4′-(CH2CH2)-D-Ala-OH. Tetrahedron Lett. 1990, 31, 5153-5156.
17. Vara Pasad, J. V. N.; Rich, D. H. Addition of Allylic Metals to Alpha-Aminoaldehydes. Application to the Synthesis of Statine, Ketomethylene and Hydroxyethylene Dipeptide Isosteres. Tetrahedron Lett. 1990, 31,1803-1806.
18. Kaltenbronn, J. S.; Hudspeth, J. P.; Lunney, E. A.; Michniewicz, B. M.; Nicolades, E. D.; Repine, J. T.; Roark, W. H.; Stier, M. A.; Tinney, F. J.; Woo, P. K. W.; Essenburg, A. D. Renin Inhibitors Containing Isosteric Replacements of the Amide Bond Connecting the P3 and P2 Sites. J. Med. Chem. 1990, 33, 838-845.
19. Mendre, C.; Rodriguez, M.; Lignon, M-F.; Galas, -C.; Gueudet, C.; Worms, P.; Martinez, J. Pharmacological Activity of Cholecystokinin Analogues Modified in the Met28-Gly29 Region. Eur. J. Pharmacol. 1990, 186, 213-222.
20. Iizuka, K.; Kamijo, T.; Harada, H.; Akahane, K. ; Kubota, T.; Umeyama, H.; Ishida, T.; Kiso, Y. Orally Potent Renin Inhibitors Derived from Angiotensinogen Transition State: Design, Synthesis and Mode of Action. J. Med. Chem. 1990, 33, 2707-2714.
21. Mendre, C.; Rodriguez, M.; Laur, J.; Aumelias, A.; Martinez, J. Peptide and Pseudopeptide Analogues of Cholecystokinin. Chemical Modifications of the Met28-Gly29 Region. Tetrahedron 1988, 44, 4415-4430.
22. Horwell, D. C.; Hughes, J.; Hunter, J. C.; Pritchard, M. C.; Richardson, R. S.; Roberts, E.; Woodruff, G. N. Rationally Designed “Dipeptoid” Analogues of CCK. Alpha-Methyltryptophan Derivatives as Highly Selective and Orally Active Gastrin and CCK-B Antagonists with Potent Anxiolytic Properties. J. Med. Chem. 1991, 34,404-414.
23. Hughes, J.; Boden, P.; Costall, B.; Domeny, A.; Kelly, E.; Horwell, D. C.; Hunter, J. C.; Pinnock, R. D.; Woodruff, G. N. Development of a Class of Selective Cholecystokinin Type B Receptor Antagonists having Potent Anxiolytic Activity. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 6728-6732.
24. Horwell, D. C.; Birchmore, B.; Boden, P. R.; Higginbottom, M.; Ping Ho, Y.; Hughes, J.; Hunter, J. C.; Richardson, R. S. Alpha-Methyl Tryptophanylphenylalanines and their Arylethylamine “Dipeptoid” Analogues of the Tetrapeptide Cholecystokinin (30-33). Eur. J. Med. Chem. 1990, 25, 53-60.
25. Horwell, D. C.; Pritchard, M. P.; Richardson, R. S.; Roberts, E.; Aranda, J. Preparation of N-Substituted Cycloalkyl and Polycycloalkyl alpha-Substituted Tryptophanylphenylalanine Analogs as Drugs. Eur. Patent 405537, 2 January 1991 (Warner-Lambert Company); Chem. Abstr. 1991, 115(5), 50307u.
26. Giannis, A.; Sandhoff, K. LiBH4(NaBH4)/Me3SiCl an Unusually Strong and Versatile Reducing Agent. Angew. Chem. Int. Ed. Engl. 1989, 28, 218-220.
27. Wenker, H. The Synthesis of A2-Oxazolines and A2-Thiazolines from JV-Acyl-2-aminoethanols. J. Am. Chem. Soc. 1935, 57, 1079-80.
28. Yokoyama, M.; Hasegawa, Y.; Hatanaka, H.; Kawazoe, Y.; Imamoto, T. Improved O/S Exchange Reagents. Synthesis 1984, 827-829.
29. Hansch, C. Quantitative Structure-Activity Relationships in Drug Design. In Drug Design; Ariens, E. J., Ed.; Academic Press: New York, 1971; pp 271-337.
30. Leo, A. J. Methods of Calculating Partition Coefficients. In Comprehensive Medicinal Chemistry; Hansch, C., Ed.; Permagon: New York, 1990; Vol. 4, pp 295-319.
31. Abraham, M. H.; Duce, P. P.; Prior, D. V.; Barratt, D. G.; Morris, J. J.; Taylor, P. J. Hydrogen Bonding. Part 9. Solute Proton Donor and Proton Acceptor Scales for Use in Drug Design. J. Chem. Soc., Perkins Trans. 2 1989, 1355-1375.
32. Jonsson, J.; Eriksson, L.; Hellberg, S.; Sjöström, M.; Wold, S. Multivariate Parametrization of 55 Coded and Non-Coded Amino Acids. Quant. Struct.-Act. Relat. 1989, 8, 204-209.
33. Parry, M. J.; Russell, A. B.; Szelke, M. Bioisosteres of a Peptide Renin Inhibitor. In Chemistry and Biology of Peptides ; Meienhofer, J., Ed.; Ann Arbor Science Publishers: Ann Arbor, MI, 1972; 541-544.
34. Coy, D. H.; Taylor, J. E.; Jiang, N-Y.; Kim, S. H.; Wang, L-H.; Huang, S.; Moreau, J-P.; Gardner, J. D.; Jensen, R. T. Short-chain Pseudopeptide Bombesin Receptor Antagonists with Enhanced Binding Affinities for Pancreatic Acinar and Swiss 3T3 Cells Displaying Strong Antimitotic Activity. J. Biol. Chem. 1989, 264, 14691-14697.
35. Martinez, J.; Bali, J-P.; Rodriguez, M.; Castro, B.; Magous, R.; Laur, J.; Lignon, M-F. Synthesis and Biological Activities of Some Pseudopeptide Analogues of Tetragastrin: The Importance of the Peptide Backbone. J. Med. Chem. 1985, 28, 1874-1879.
36. Qian, J-M.; Coy, D. H.; Jiang, N-Y.; Gardner, J. D.; Jensen, R. T. Reduced Peptide Bond Pseudopeptide Analogues of Substance P. J. Biol. Chem. 1989, 264, 16667-16671.
37. Hocart, S. J.; Murphy, W. A.; Coy, D. H. Analogues of Growth Hormone-Releasing Factor (1-29) Amide Containing the Reduced Peptide Bond Isostere in the N-Terminal Region. J. Med. Chem. 1990, 33, 1954-1958.
38. Haffar, B. M.; Hocart, S. J.; Coy, D. H.; Mantey, S.; Victor Chiang, H-C.; Jensen, R. T. Reduced Peptide Bond Pseudopeptide Analogues of Secretin. J. Biol. Chem. 1991, 266, 316-322.
39. Horwell, D. C.; Ratcliffe, G.; Roberts, E. Stabilities of Tryptophanylphenethylamides to Acid and Alkaline Conditions. BioMed. Chem. Lett. 1991, 1, 169-172.
40. Labanowski, J.; Motoc, I.; Naylor, C. B.; Mayer, D.; Dammkoehler, R. A. Three Dimensional Quantitative Structure-Activity Relationships. 2. Conformational Mimicry and Topological Similarity of Flexible Molecules. Quant. Struct.-Act. Relat. 1986, 5, 138-152.
41. Clark, M.; Cramer, D., III; Van Opdenbosch, N. Validation of the Tripos 5.2 Force Field. J. Comput. Chem. 1989, 10, 982-1012.
42. Vinter, J. G.; Davis, A.; Saunders, M. R. Strategic Approaches to Drug Design. 1. An Integral Software Framework for Molecular Modelling. J. Comput.-Aided Mol. Des. 1987, 1, 31-51.
43. Greidanus, J. W. Chemistry of 2-Substituted Adamantanes. V. Photolysis of 2-Adamantyl Azidoformate. Can. J. Chem. 1974, 52, 1062-1065.